Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New phonics program aims to catch learning disorders early in school kids

NCT ID NCT07510126

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a structured phonics program called ALFABETO in first and second graders to see if it improves reading and writing more than usual teaching methods. About 1,400 children from schools in Italy will take part, with some classes using the program and others using their standard approach. The goal is to help all children learn better and to identify those who may have a specific learning disorder (like dyslexia) so they can get early support.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,407 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 6 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Children who will attend, starting in September 2025, first-grade classes of schools in the FVG region: * who have accepted the participation in the project * with Italian as the primary language * with at least two first-grade (non-multigrade) classes in which Italian is taught as the primary language by different teachers, following curricula that do not include Montessori, Waldorf, Pizzigoni, or Agazzi. Inclusion Criteria: Written Informed consent for screening tests signed by parents Exclusion Criteria: Children who need differentiated teaching programming with a dedicated teacher (L.104 Comma 1 e 3)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acquisition of literacy skills for all children, including those with SLDS, appropriateness of referrals for SLD assessment for accurate early detection of SLDS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinical Epidemilogy and Public Health Research Unit, Institute for Maternal and Child Health IRCCS Burlo Garofolo

    Trieste, Trieste, 34137, Italy